Paradromics Receives FDA Approval to Expand Connexus® Brain-Computer Interface ...

Paradromics received FDA approval to remove the geographic restriction for participant recruitment in its Connect-One brain-computer interface study, allowing eligible individuals across the U.S. to participate. The study, conducted at three academic medical centers, evaluates the safety and performance of the implantable Connexus BCI for restoring communication in people with severe motor impairment.

This Wire brief sits within Fusion42's coverage of Medtech.